Internal Medicine Alert – December 15, 2010
December 15, 2010
View Archives Issues
-
Which Acute Headaches Do Not Require Investigation?
Easily obtained clinical variables can identify patients at very low risk for subarachnoid hemorrhage. -
Most Prostate Cancer Does Not Need Initial Treatment
A decision analysis shows that active surveillance is a good option for men age 65 and older with low-risk prostate cancer (Gleason score of 6 or less). Active surveillance results in the highest quality-of-life scores compared with different treatment options, and 61% of these men will go on to treatment after a median of 8.5 years, with a slight increased mortality risk. Only 10% of men currently receive active surveillance for low-risk prostate cancer -
Predictors of Mortality in Parkinson's Disease
Clinical predictors of mortality in Parkinson's disease include age at onset, chronological age, male sex, motor severity, psychosis, and dementia -
Drospirone/Ethinyl Estradiol/Levomefolate Calcium Tablets (Beyaz™)
The first oral contraceptive combined with a folate has been approved by the FDA. -
Clinical Briefs By Louis Kuritzky, MD
The most recent advice from the U.S. Department of Agriculture (2005) recommends that the general population of adults not consume > 2300 mg/day of sodium, and that persons with hypertension (HTN) consume ≤ 1500 mg/day. -
ECG Review: A Burst of VT?
The ECG shown above was obtained from an older man with palpitations. He was hemodynamically stable with a systolic BP of 140 mm Hg at the time this tracing was recorded. How do you interpret the rhythm? What are your initial priorities? -
Pharmacology Watch
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions